Project Details
Description
Using structural information, we created a conformation-specific vaccine
against a-synuclein neurotoxic aggregates. We aim to validate it as a best-inclass
preventive therapy for Parkinson's Disease.
against a-synuclein neurotoxic aggregates. We aim to validate it as a best-inclass
preventive therapy for Parkinson's Disease.
| Acronym | NEUROVAX |
|---|---|
| Status | Active |
| Effective start/end date | 1/12/25 → 30/11/28 |
Collaborative partners
- Spanish National Research Council (CSIC)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.